Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study

NCT04075825 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04075825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
November 5, 2019
Completion date
April 2, 2024
Enrollment
150 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

complex perianal fistula, crohn's disease